WASHINGTON—A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the ...
In recent years, GLP-1 medications such as Ozempic, Wegovy and Zepbound have ballooned in popularity. While GLP-1s have, for years, been a prescribed treatment for type 2 diabetes, they now are an FDA ...
BRIAN BOYCE FROM SPRINGBORO, PA: Do you think the Steelers should have played Skylar Thompson against Carolina's 1s and 2s last Thursday night? Then play Mason Rudolph in the second half. This could ...
New play in transition metal chemistry playbook revealed. New research shows that net oxidative addition can occur via a different order of events in which the transitiion metal complex accepts ...
The AYANEO Flip 1S is a clamshell handheld with dual-screen and keyboard variants. It runs Windows, with a Ryzen 7 8840U or Ryzen AI 9 HX 370 chipset. Pre-orders start today at $779, with shipping ...
Anywhere from 6% to 12% of the US population has taken a GLP-1 agonist. But until now there hasn’t been a cohesive message among physicians for how to care for this growing patient population. Last ...
DUBLIN--(BUSINESS WIRE)--The "Software-Defined Vehicle (SDV) Architecture Market 2025-2035: Strategic Insights for OEMs, Tier-1s, and Tech Giants" report has been added to ResearchAndMarkets.com's ...
On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...
Catch up on some of SCMP’s biggest China stories of the day. If you would like to see more of our reporting, please consider subscribing. 1. US and China begin crunch trade talks in London amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback